Delcath Systems reports preliminary 2025 revenue of $85.2 million

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. XYZ
8. SWKS
9. FISV
10. CVS

Go back to Delcath Systems reports preliminary 2025 revenue of $85.2 million

Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results

January 9, 2026 8:05 AM EST

QUEENSBURY, N.Y.--(BUSINESS WIRE)-- Delcath Systems, Inc. (Nasdaq: DCTH) (Delcath or the Company), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced preliminary financial results and business updates for the fourth quarter and year-ended December 31, 2025.

Preliminary Fourth Quarter and Full-Year 2025 Financial Results (unaudited)

Total fourth quarter and full year revenue expected to be approximately $20.7 million and $85.2 million, respectively HEPZATO KIT fourth quarter and full year revenue expected to be approximately $19.0 million and $78.8 million,... More